Anna Brodska
When Breast Implants Need Replacing
The familiar rule that implants “must be changed every ten years” is too simple. Breast implants are not lifetime devices, and the likelihood of complications and further surgery increases over time. Yet an anniversary alone, without symptoms, imaging findings or another concern, is not always an indication for automatic replacement.
I consider the implant type and model, shell integrity, capsule and surrounding tissue, changes in shape, pain, ultrasound or MRI findings, and the patient’s goals—not age alone.
New enlargement, swelling, firmness, pain, a lump, asymmetry or shape change in a breast with an implant requires an in-person assessment. A photograph cannot diagnose rupture or contracture.
Is there a mandatory replacement date?
No universal date applies to everyone. The FDA states that implants are not lifetime devices and their individual lifespan cannot be predicted. This means lifelong awareness and the possibility of future surgery, not replacement of every functioning device on the same schedule.
| Situation | Does it automatically mean replacement? | Next step |
|---|---|---|
| Ten years have passed, no concerns | Not necessarily | Review device records and complete recommended clinical and imaging follow-up |
| Rupture is confirmed | Often requires a surgical plan | Discuss removal, replacement and capsule management |
| Painful hardness and distortion | May represent capsular contracture | Examination, imaging and an individual decision |
| Shape changed after pregnancy or weight loss | Not always a device problem | Assess implant and native tissue separately |
| The patient wants a different size or removal | A valid elective decision | Discuss tissue consequences, alternatives and possible lift |
Changes that may lead to revision
- confirmed or suspected rupture;
- significant capsular contracture with hardness, pain or distortion;
- displacement, rotation or malposition;
- infection, exposure or healing problems;
- late fluid, new breast enlargement or a mass;
- persistent pain or another unexplained change;
- a personal decision to change size or remove implants.
Not every ripple, asymmetry or post-pregnancy change means the device is damaged. Skin, glandular tissue, weight and the chest wall continue to change independently.
A rupture can be silent
A saline implant usually deflates visibly when its shell fails. Silicone-gel rupture may be silent: appearance can remain similar and physical examination alone may miss it.
Current FDA labelling recommends that asymptomatic patients with silicone implants have their first ultrasound or MRI 5–6 years after surgery, then every 2–3 years. MRI may be advised for symptoms or an equivocal ultrasound. Follow the plan for your exact device and clinical circumstances.
A structured assessment
- Locate the implant card and operation record: manufacturer, model, size, surface and date.
- Describe when changes began and whether pain, swelling or fever is present.
- Have the breasts, scars, nodes and implant position examined.
- Complete prescribed ultrasound or MRI; this does not replace breast-cancer screening.
- Discuss every option rather than assuming like-for-like replacement.
- Obtain a follow-up or surgical plan that addresses the capsule and tissues.
Observe, replace or remove?
| Option | When it may be considered | Important consideration |
|---|---|---|
| Observation | No clinical problem and no operative indication | Continue follow-up and report new changes promptly |
| Replacement | Rupture, contracture, displacement or desired parameter change | New device risks and the state of pocket and tissue |
| Removal without replacement | Personal choice or medical indication | Potential volume loss, folds or loose skin |
| Removal with lift | Tissue also needs reshaping | Additional scars, blood supply and operative extent |
Capsule management is individual too. Complete capsulectomy is not automatically required in every case and can add surgical trauma; the indication depends on the implant, capsule and surrounding tissues.
Symptoms that should not wait
Seek assessment for sudden or gradual one-sided enlargement, new fluid, a lump, rash, hardness, pain, shape change or enlarged lymph nodes. These findings do not establish a diagnosis, but they require evaluation, including consideration of rare capsule-associated complications.
Relevant information: breast implant revision, mastopexy with implants and how implant size is selected.
Frequently asked questions
If I feel well, can I skip follow-up?
No. Lack of symptoms does not exclude silent silicone rupture. Follow your agreed schedule.
Must both implants be replaced if one has a problem?
Not always. Both sides are assessed and age, symmetry and patient preference are discussed.
Does mammography check implant integrity?
Its principal purpose is breast-tissue screening. Dedicated ultrasound or MRI may be needed for silicone implant integrity.
Can implants simply be removed?
Yes, but the appearance afterward depends on native volume, skin stretch and capsule condition; a lift may be discussed.
The key point
Ten years is not an expiry date requiring automatic replacement. Implants are nevertheless not lifetime devices and require monitoring. I base the decision on the device, capsule, tissues, symptoms, imaging and the patient’s informed goals.
Sources
- FDA: types of breast implants
- FDA: implant risks and complications
- FDA: rupture-screening guidance
- ASPS: breast implant revision
Medical review: Anna Brodska, plastic surgeon. Updated 7 September 2026.
